# Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/afatinib-for-patients-with-lung-adenocarcinoma-and-epidermal-growth-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | James Chih‐Hsin Yang,Jin‐Yuan Shih,Wu‐Chou Su,Te‐Chun Hsia,Chun-Ming Tsai,Sai‐Hong Ignatius Ou,Chong‐Jen Yu,Gee‐Chen Chang,Ching-Liang Ho,Lecia V. Sequist,Arkadiusz Z. Dudek,Mehdi Shahidi,Xiuyu Julie Cong,Robert M. Lorence,Pan‐Chyr Yang,Vincent A. Miller |
| Citations | 408 |
| DOI | 10.1016/s1470-2045(12)70086-4 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2160336497 |
| PMID | 22452895 |
| Type | article |
| Year | 2012 |

## Paper authors

- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)
- [Jin‐Yuan Shih](https://scholariq.org/researchers/jin-yuan-shih/)
- [Lecia V. Sequist](https://scholariq.org/researchers/lecia-v-sequist/)
- [Chong‐Jen Yu](https://scholariq.org/researchers/chong-jen-yu/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.